Does lenalidomide plus dexamethasone improve outcome in patients with relapsed multiple myeloma?
Dhodapkar
Madhav V
MV
Department of Hematology and Director of Hematologic Malignancies Yale Cancer Center, CT 06520, USA. madhav.dhodapkar@yale.edu
Cooper
Dennis L
DL